End-of-day quote
Colombo S.E.
18:00:00 2024-05-08 EDT
|
5-day change
|
1st Jan Change
|
23.5
LKR
|
0.00%
|
|
0.00%
|
+4.44%
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Capitalization
1 |
1,126
|
1,212
|
1,272
|
1,583
|
1,715
|
1,503
|
Enterprise Value (EV)
1 |
805.1
|
1,042
|
1,104
|
1,070
|
1,723
|
1,509
|
P/E ratio
|
5.47
x
|
2.43
x
|
5.6
x
|
7.89
x
|
7.25
x
|
41.5
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
0.95
x
|
0.77
x
|
0.68
x
|
0.78
x
|
0.68
x
|
0.54
x
|
EV / Revenue
|
0.68
x
|
0.66
x
|
0.59
x
|
0.52
x
|
0.68
x
|
0.54
x
|
EV / EBITDA
|
3.69
x
|
4.76
x
|
3.08
x
|
3.28
x
|
4.43
x
|
11.1
x
|
EV / FCF
|
72.5
x
|
4.55
x
|
4.88
x
|
2.77
x
|
8.98
x
|
2.22
x
|
FCF Yield
|
1.38%
|
22%
|
20.5%
|
36.1%
|
11.1%
|
45.1%
|
Price to Book
|
1.21
x
|
0.85
x
|
0.77
x
|
0.85
x
|
0.83
x
|
0.78
x
|
Nbr of stocks (in thousands)
|
66,230
|
66,230
|
66,230
|
66,230
|
66,230
|
66,230
|
Reference price
2 |
17.00
|
18.30
|
19.20
|
23.90
|
25.90
|
22.70
|
Announcement Date
|
4/3/18
|
5/30/19
|
8/19/20
|
4/30/21
|
4/20/22
|
5/30/23
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net sales
1 |
1,187
|
1,583
|
1,866
|
2,041
|
2,518
|
2,799
|
EBITDA
1 |
218.1
|
219
|
358.5
|
325.9
|
389.1
|
135.5
|
EBIT
1 |
206
|
198.8
|
335.2
|
300.5
|
361.2
|
109.7
|
Operating Margin
|
17.35%
|
12.56%
|
17.96%
|
14.72%
|
14.34%
|
3.92%
|
Earnings before Tax (EBT)
1 |
206
|
198.8
|
316.1
|
278.6
|
337.4
|
85.19
|
Net income
1 |
206
|
499.2
|
227.3
|
200.7
|
236.7
|
36.24
|
Net margin
|
17.35%
|
31.54%
|
12.18%
|
9.83%
|
9.4%
|
1.29%
|
EPS
2 |
3.111
|
7.537
|
3.431
|
3.030
|
3.574
|
0.5471
|
Free Cash Flow
1 |
11.1
|
229
|
226.5
|
386.3
|
191.8
|
680.3
|
FCF margin
|
0.93%
|
14.47%
|
12.14%
|
18.92%
|
7.62%
|
24.31%
|
FCF Conversion (EBITDA)
|
5.09%
|
104.61%
|
63.17%
|
118.52%
|
49.3%
|
502.21%
|
FCF Conversion (Net income)
|
5.39%
|
45.88%
|
99.66%
|
192.49%
|
81.05%
|
1,877.49%
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
4/3/18
|
5/30/19
|
8/19/20
|
4/30/21
|
4/20/22
|
5/30/23
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
7.43
|
5.59
|
Net Cash position
1 |
321
|
170
|
167
|
513
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
0.0191
x
|
0.0413
x
|
Free Cash Flow
1 |
11.1
|
229
|
226
|
386
|
192
|
680
|
ROE (net income / shareholders' equity)
|
24.4%
|
42.2%
|
14.7%
|
11.4%
|
12%
|
1.82%
|
ROA (Net income/ Total Assets)
|
6.98%
|
4.87%
|
6.31%
|
4.8%
|
5.25%
|
1.52%
|
Assets
1 |
2,953
|
10,244
|
3,603
|
4,180
|
4,505
|
2,389
|
Book Value Per Share
2 |
14.10
|
21.60
|
25.10
|
28.10
|
31.30
|
28.90
|
Cash Flow per Share
2 |
4.840
|
2.570
|
4.460
|
10.10
|
2.270
|
2.560
|
Capex
1 |
47.8
|
25.6
|
20.4
|
24.3
|
26.6
|
43.4
|
Capex / Sales
|
4.03%
|
1.62%
|
1.09%
|
1.19%
|
1.06%
|
1.55%
|
Announcement Date
|
4/3/18
|
5/30/19
|
8/19/20
|
4/30/21
|
4/20/22
|
5/30/23
|
|
1st Jan change
|
Capi.
|
---|
| +4.44% | 5.19M | | +12.72% | 80B | | +10.00% | 51.49B | | +4.42% | 48.79B | | +20.46% | 46.12B | | +14.49% | 42.3B | | +28.76% | 41.03B | | +0.44% | 29.42B | | -2.19% | 29.33B | | -10.75% | 27.19B |
Other Life & Health Insurance
|